Enterprise Therapeutics: Niyati Prasad, chief medical officer
Enterprise Therapeutics, a pharma company focused on respiratory disease therapies, has named Niyati Prasad chief medical officer. Prasad will be based in the UK and offer support in advancement of the company’s various clinical programs.
John Ford, CEO of Enterprise Therapeutics, said, “Niyati’s long-standing expertise in respiratory drug development and impressive track record in directing clinical programs will be an invaluable asset to Enterprise. We are confident that Dr. Prasad will play a key role in progressing our novel respiratory therapies through the clinic.”